000 | 01853 a2200517 4500 | ||
---|---|---|---|
005 | 20250517131532.0 | ||
264 | 0 | _c20171102 | |
008 | 201711s 0 0 eng d | ||
022 | _a1463-1326 | ||
024 | 7 |
_a10.1111/dom.12859 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRadhakutty, Anjana | |
245 | 0 | 0 |
_aTreatment of prednisolone-induced hyperglycaemia in hospitalized patients: Insights from a randomized, controlled study. _h[electronic resource] |
260 |
_bDiabetes, obesity & metabolism _c04 2017 |
||
300 |
_a571-578 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHospitalization |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperglycemia _xchemically induced |
650 | 0 | 4 |
_aHypoglycemia _xchemically induced |
650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
650 | 0 | 4 | _aInpatients |
650 | 0 | 4 |
_aInsulin _xadministration & dosage |
650 | 0 | 4 |
_aInsulin Aspart _xadministration & dosage |
650 | 0 | 4 |
_aInsulin Glargine _xadministration & dosage |
650 | 0 | 4 |
_aInsulin, Isophane _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMeals |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPrednisolone _xadverse effects |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aStranks, Jessica L | |
700 | 1 | _aMangelsdorf, Brenda L | |
700 | 1 | _aDrake, Sophie M | |
700 | 1 | _aRoberts, Gregory W | |
700 | 1 | _aZimmermann, Anthony T | |
700 | 1 | _aStranks, Stephen N | |
700 | 1 | _aThompson, Campbell H | |
700 | 1 | _aBurt, Morton G | |
773 | 0 |
_tDiabetes, obesity & metabolism _gvol. 19 _gno. 4 _gp. 571-578 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/dom.12859 _zAvailable from publisher's website |
999 |
_c26714695 _d26714695 |